{"id":60656,"date":"2024-02-28T07:01:04","date_gmt":"2024-02-28T07:01:04","guid":{"rendered":"https:\/\/medsname.com\/valprol-cr\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"valprol-cr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/valprol-cr\/","title":{"rendered":"Valprol-CR"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Valprol-CR?<\/h3>\n<p style=\"margin:0;\"><strong>Valprol-CR<\/strong> je peror\u00e1ln\u00ed <strong>tableta s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm<\/strong> od spole\u010dnosti Intas Pharmaceuticals obsahuj\u00edc\u00ed <strong>valpro\u00e1t sodn\u00fd + kyselina valproov\u00e1<\/strong> \u2014 \u0161irokospektr\u00e9 antiepileptikum, stabiliz\u00e1tor n\u00e1lady a l\u00e9k na profylaxi migr\u00e9ny. Dostupn\u00e9 v <strong>200 mg a 750 mg<\/strong> CR s\u00edle. Pou\u017e\u00edv\u00e1 se pro: <strong>r\u016fzn\u00fdch typ\u016f z\u00e1chvat\u016f u epilepsie<\/strong> (generalizovan\u00e9 tonicko-klonick\u00e9, absence, myoklonick\u00e9, parci\u00e1ln\u00ed), <strong>akutn\u00ed m\u00e1nie u bipol\u00e1rn\u00ed poruchy I. typu<\/strong>, a <strong>profylaxe migr\u00e9ny<\/strong>. D\u00e1vkov\u00e1n\u00ed u dosp\u011bl\u00fdch: 600\u20132 500 mg\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch. U\u017e\u00edvejte s j\u00eddlem nebo po j\u00eddle, aby se sn\u00ed\u017eily gastrointestin\u00e1ln\u00ed pot\u00ed\u017ee. <strong>FDA t\u011bhotensk\u00e1 kategorie X pro migr\u00e9nu, kategorie D pro epilepsii<\/strong> \u2014 jeden z nejv\u00edce teratogenn\u00edch l\u00e9k\u016f v rutinn\u00ed klinick\u00e9 praxi. \u017deny v reproduk\u010dn\u00edm v\u011bku pot\u0159ebuj\u00ed explicitn\u00ed poradenstv\u00ed o prevenci t\u011bhotenstv\u00ed a m\u011bly by se valpro\u00e1tu obvykle vyh\u00fdbat, pokud jin\u00e9 mo\u017enosti selhaly. Povinn\u00e9 monitorov\u00e1n\u00ed: <strong>v\u00fdchoz\u00ed + periodick\u00e9 jatern\u00ed testy, krevn\u00ed obraz, hladina amoniaku, pokud jsou p\u0159\u00edznaky.<\/strong>. Nikdy nep\u0159est\u00e1vejte n\u00e1hle \u2014 n\u00e1hl\u00e9 vysazen\u00ed m\u016f\u017ee vyvolat status epilepticus.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Valprol-CR?<\/h2>\n<p>Valprol-CR je peror\u00e1ln\u00ed tableta s kontrolovan\u00fdm uvol\u0148ov\u00e1n\u00edm od spole\u010dnosti Intas Pharmaceuticals obsahuj\u00edc\u00ed <strong>valpro\u00e1t sodn\u00fd<\/strong> v kombinaci s <strong>kyselinou valproovou<\/strong> (stejn\u00e1 aktivn\u00ed molekula, r\u016fzn\u00e1 s\u016fl \u2014 v roztoku jsou ekvivalentn\u00ed). Formulace CR (kontrolovan\u00e9 uvol\u0148ov\u00e1n\u00ed) postupn\u011b uvol\u0148uje \u00fa\u010dinnou l\u00e1tku po dobu 12\u201324 hodin, co\u017e umo\u017e\u0148uje jednodenn\u00ed nebo dvakr\u00e1t denn\u00ed d\u00e1vkov\u00e1n\u00ed nam\u00edsto t\u0159\u00ed- nebo \u010dty\u0159ikr\u00e1t denn\u00edho re\u017eimu pot\u0159ebn\u00e9ho u valpro\u00e1tu s okam\u017eit\u00fdm uvol\u0148ov\u00e1n\u00edm.<\/p>\n<p>Valpro\u00e1t je jedno z nejstar\u0161\u00edch a nej\u0161irokospektr\u00e1ln\u011bj\u0161\u00edch antiepileptik v u\u017e\u00edv\u00e1n\u00ed. Je schv\u00e1len pro r\u016fzn\u00e9 typy z\u00e1chvat\u016f p\u0159i epilepsii, akutn\u00ed m\u00e1nii u bipol\u00e1rn\u00ed poruchy I. typu a profylaxi migr\u00e9ny. Formulace CR je preferov\u00e1na u dosp\u011bl\u00fdch, kte\u0159\u00ed vy\u017eaduj\u00ed udr\u017een\u00ed hladiny l\u00e9ku po 24 hodin \u2014 zejm\u00e9na u t\u011bch, kte\u0159\u00ed poci\u0165uj\u00ed vrcholov\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky (ospalost, t\u0159es) u valpro\u00e1tu s okam\u017eit\u00fdm uvol\u0148ov\u00e1n\u00edm.<\/p>\n<h2 class=\"wp-block-heading\">Jak funguje Valprol-CR?<\/h2>\n<p>Valpro\u00e1t sodn\u00fd m\u00e1 v\u00edce dopl\u0148uj\u00edc\u00edch se mechanism\u016f, kter\u00e9 spole\u010dn\u011b vytv\u00e1\u0159ej\u00ed jeho \u0161irokospektr\u00e1ln\u00ed protiz\u00e1chvatov\u00e9 a stabilizuj\u00edc\u00ed n\u00e1ladu \u00fa\u010dinky:<\/p>\n<ul>\n<li><strong>Blok\u00e1da nap\u011b\u0165ov\u011b \u0159\u00edzen\u00fdch sod\u00edkov\u00fdch kan\u00e1l\u016f<\/strong> \u2014 sni\u017euje vysokofrekven\u010dn\u00ed neuron\u00e1ln\u00ed v\u00fdboje, co\u017e je z\u00e1klad jeho protiz\u00e1chvatov\u00e9ho \u00fa\u010dinku u parci\u00e1ln\u00edch a generalizovan\u00fdch tonicko-klonick\u00fdch z\u00e1chvat\u016f.<\/li>\n<li><strong>Inhibice T-typov\u00fdch kalciov\u00fdch kan\u00e1l\u016f<\/strong> \u2014 zvl\u00e1\u0161t\u011b relevantn\u00ed pro absence, kde T-typ v\u00e1pn\u00edkov\u00fdch proud\u016f v thalamokortik\u00e1ln\u00edch neuronech \u0159\u00edd\u00ed vzorec spike-wave.<\/li>\n<li><strong>Pos\u00edlen\u00ed GABAergn\u00edho syst\u00e9mu<\/strong> \u2014 zvy\u0161uje koncentraci GABA v mozku inhibic\u00ed enzym\u016f degraduj\u00edc\u00edch GABA (GABA-T a sukcin\u00e1t semialdehyd dehydrogen\u00e1za) a zv\u00fd\u0161enou synt\u00e9zou GABA.<\/li>\n<li><strong>Modulace NMDA receptor\u016f<\/strong> \u2014 sni\u017euje excita\u010dn\u00ed glutam\u00e1tov\u00fd p\u0159enos.<\/li>\n<\/ul>\n<p>Kombinovan\u00fd efekt p\u0159edstavuje \u0161irok\u00e9 terapeutick\u00e9 spektrum nap\u0159\u00ed\u010d typy z\u00e1chvat\u016f, stabiliza\u010dn\u00ed \u00fa\u010dinek na n\u00e1ladu u bipol\u00e1rn\u00ed poruchy I. typu a profylaxi migr\u00e9ny prost\u0159ednictv\u00edm potla\u010den\u00ed kortik\u00e1ln\u00ed \u0161\u00ed\u0159\u00edc\u00ed se deprese.<\/p>\n<h2 class=\"wp-block-heading\">Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>Epilepsie \u2014 generalizovan\u00e9 tonicko-klonick\u00e9 z\u00e1chvaty<\/strong> (prvn\u00ed volba)<\/li>\n<li><strong>Epilepsie \u2014 absence<\/strong> (prvn\u00ed volba, zejm\u00e9na u d\u011btsk\u00e9ho a juveniln\u00edho po\u010d\u00e1tku)<\/li>\n<li><strong>Epilepsie \u2014 myoklonick\u00e9 z\u00e1chvaty<\/strong> (l\u00e9k prvn\u00ed volby u juveniln\u00ed myoklonick\u00e9 epilepsie)<\/li>\n<li><strong>Epilepsie \u2014 parci\u00e1ln\u00ed (fok\u00e1ln\u00ed) z\u00e1chvaty<\/strong> (s nebo bez sekund\u00e1rn\u00ed generalizace)<\/li>\n<li><strong>Lennox-Gastautov\u011b syndromu<\/strong> a dal\u0161\u00ed sm\u00ed\u0161en\u00e9 typy z\u00e1chvat\u016f<\/li>\n<li><strong>Bipol\u00e1rn\u00ed porucha I. typu \u2014 akutn\u00ed m\u00e1nie<\/strong> (monoterapie schv\u00e1len\u00e1 FDA)<\/li>\n<li><strong>Bipol\u00e1rn\u00ed porucha I. typu \u2014 udr\u017eovac\u00ed l\u00e9\u010dba<\/strong> (mimo indikaci, \u0161iroce pou\u017e\u00edvan\u00e9)<\/li>\n<li><strong>Profylaxe migr\u00e9ny<\/strong> u dosp\u011bl\u00fdch (schv\u00e1leno FDA p\u0159i \u010dast\u00fdch a invalidizuj\u00edc\u00edch migr\u00e9n\u00e1ch)<\/li>\n<li><strong>Mimo indikaci:<\/strong> behavior\u00e1ln\u00ed agitace u demence (ji\u017e nedoporu\u010dov\u00e1no \u2014 sign\u00e1l mortality), agrese a kontrola impulz\u016f, neuropatick\u00e1 bolest<\/li>\n<\/ul>\n<p>Valprol-CR je <strong>ne<\/strong> prvn\u00ed volba pro: \u017eeny v reproduk\u010dn\u00edm v\u011bku, kter\u00e9 by mohly ot\u011bhotn\u011bt (kv\u016fli teratogenit\u011b), \u010dist\u00e9 absence u mal\u00fdch d\u011bt\u00ed, pokud je k dispozici ethosuximid (lep\u0161\u00ed bezpe\u010dnostn\u00ed profil), nebo generalizovan\u00e1 \u00fazkost\/nemonopol\u00e1rn\u00ed deprese. <strong>Behavior\u00e1ln\u00ed agitace u demence ji\u017e nen\u00ed doporu\u010dovanou indikac\u00ed<\/strong> \u2014 observa\u010dn\u00ed data nazna\u010duj\u00ed zv\u00fd\u0161enou mortalitu, podobn\u011b jako u sign\u00e1lu antipsychotik u demence.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed Valprol-CR a jak ho u\u017e\u00edvat<\/h2>\n<p>Valprol-CR je dostupn\u00fd v <strong>200 mg<\/strong> a <strong>750 mg<\/strong> kontrolovan\u00fdch d\u00e1vk\u00e1ch.<\/p>\n<p><strong>Standardn\u00ed d\u00e1vkov\u00e1n\u00ed pro dosp\u011bl\u00e9 podle indikace:<\/strong><\/p>\n<ul>\n<li><strong>Epilepsie:<\/strong> Za\u010dn\u011bte s 600 mg\/den (300 mg dvakr\u00e1t denn\u011b). Zvy\u0161ujte o 200 mg ka\u017ed\u00e9 3 dny podle kontroly z\u00e1chvat\u016f. Udr\u017eovac\u00ed d\u00e1vka 1 000\u20132 000 mg\/den v 1\u20132 d\u00edl\u010d\u00edch d\u00e1vk\u00e1ch. Maximum 2 500 mg\/den.<\/li>\n<li><strong>Bipol\u00e1rn\u00ed porucha I. typu (akutn\u00ed m\u00e1nie):<\/strong> Za\u010dn\u011bte s 750 mg\/den v d\u00edl\u010d\u00edch d\u00e1vk\u00e1ch; rychle zvy\u0161ujte k dosa\u017een\u00ed s\u00e9rov\u00e9 hladiny 50\u2013125 \u00b5g\/ml. Udr\u017eovac\u00ed d\u00e1vka 1 000\u20132 500 mg\/den.<\/li>\n<li><strong>Profylaxe migr\u00e9ny:<\/strong> Za\u010dn\u011bte s 250 mg dvakr\u00e1t denn\u011b; v p\u0159\u00edpad\u011b pot\u0159eby zvy\u0161te na 500\u20131 000 mg\/den. Mnoho pacient\u016f reaguje ji\u017e p\u0159i 500 mg\/den.<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">Jak spr\u00e1vn\u011b u\u017e\u00edvat Valprol-CR<\/h3>\n<ol>\n<li><strong>U\u017e\u00edvejte s j\u00eddlem nebo po j\u00eddle.<\/strong> Toto je nejv\u011bt\u0161\u00ed faktor ovliv\u0148uj\u00edc\u00ed gastrointestin\u00e1ln\u00ed sn\u00e1\u0161enlivost. U\u017e\u00edv\u00e1n\u00ed nala\u010dno zp\u016fsobuje u v\u011bt\u0161iny pacient\u016f nevolnost, dyspepsii a bolesti b\u0159icha.<\/li>\n<li><strong>Polykejte cel\u00e9 s vodou.<\/strong> NE dr\u0165te, ned\u011blte a ne\u017ev\u00fdkejte tablety s kontrolovan\u00fdm uvol\u0148ov\u00e1n\u00edm \u2014 to ni\u010d\u00ed mechanismus kontrolovan\u00e9ho uvol\u0148ov\u00e1n\u00ed a zp\u016fsob\u00ed n\u00e1hl\u00e9 uvoln\u011bn\u00ed d\u00e1vky s t\u011b\u017ek\u00fdmi vrcholov\u00fdmi ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky (ospalost, t\u0159es, GI pot\u00ed\u017ee).<\/li>\n<li><strong>Dvakr\u00e1t denn\u011b pro v\u011bt\u0161inu dosp\u011bl\u00fdch<\/strong>, ide\u00e1ln\u011b r\u00e1no a ve\u010der s 12hodinov\u00fdm odstupem. Jednor\u00e1zov\u00e9 denn\u00ed pod\u00e1n\u00ed (cel\u00e1 denn\u00ed d\u00e1vka p\u0159ed span\u00edm) je rozumn\u00e9 u profylaxe migr\u00e9ny p\u0159i 500\u20131 000 mg\/den.<\/li>\n<li><strong>Dodr\u017eujte pravideln\u00fd \u010das u\u017e\u00edv\u00e1n\u00ed.<\/strong> Vynechan\u00e9 d\u00e1vky vedou k znateln\u00fdm pokles\u016fm hladin. Pokud si na d\u00e1vku vzpomenete do 6 hodin, vezm\u011bte ji. Pokud uplynulo &gt;6 hodin, vynechejte a pokra\u010dujte norm\u00e1ln\u011b \u2014 ned\u00e1vejte dvojn\u00e1sobnou d\u00e1vku.<\/li>\n<li><strong>Monitorovac\u00ed pl\u00e1n:<\/strong> v\u00fdchoz\u00ed jatern\u00ed testy (AST, ALT, GGT), kompletn\u00ed krevn\u00ed obraz a po\u010det trombocyt\u016f <strong>p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby<\/strong>. Opakujte po <strong>1 m\u011bs\u00edci<\/strong>, <strong>3 m\u011bs\u00edce<\/strong>, <strong>6 m\u011bs\u00edc\u016f<\/strong>, pot\u00e9 ro\u010dn\u011b. Hladinu amoniaku zkontrolujte, pokud se u pacienta objev\u00ed ospalost, zmatenost nebo zvracen\u00ed.<\/li>\n<li><strong>Monitorov\u00e1n\u00ed hladiny l\u00e9ku:<\/strong> hladina valpro\u00e1tu v s\u00e9ru je u\u017eite\u010dn\u00e1 u epilepsie (c\u00edlov\u00e9 rozmez\u00ed 50\u2013100 \u00b5g\/ml) a bipol\u00e1rn\u00ed poruchy (c\u00edlov\u00e9 rozmez\u00ed 50\u2013125 \u00b5g\/ml). U profylaxe migr\u00e9ny se rutinn\u011b nevy\u017eaduje.<\/li>\n<li><strong>Nikdy nep\u0159est\u00e1vejte n\u00e1hle.<\/strong> N\u00e1hl\u00e9 vysazen\u00ed u epilepsie m\u016f\u017ee vyvolat <strong>status epilepticus<\/strong> (l\u00e9ka\u0159sk\u00e1 pohotovost) i u pacient\u016f, kte\u0159\u00ed byli roky bez z\u00e1chvat\u016f. P\u0159i ukon\u010dov\u00e1n\u00ed l\u00e9\u010dby sni\u017eujte d\u00e1vky postupn\u011b po dobu 2\u20136 t\u00fddn\u016f pod l\u00e9ka\u0159sk\u00fdm dohledem.<\/li>\n<li><strong>Prevence t\u011bhotenstv\u00ed<\/strong> (\u017eeny v reproduk\u010dn\u00edm v\u011bku): po celou dobu l\u00e9\u010dby pou\u017e\u00edvejte spolehlivou antikoncepci. Proberte alternativn\u00ed l\u00e9ky, pokud existuje mo\u017enost t\u011bhotenstv\u00ed \u2014 valpro\u00e1t pat\u0159\u00ed mezi nejv\u00edce teratogenn\u00ed l\u00e9ky v b\u011b\u017en\u00e9 klinick\u00e9 praxi.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky p\u0159\u00edpravku Valprol-CR<\/h2>\n<p><strong>\u010cast\u00e9 (\u010dasto z\u00e1visl\u00e9 na d\u00e1vce, mohou ustoupit p\u0159i pomalej\u0161\u00ed titraci):<\/strong><\/p>\n<ul>\n<li>Nevolnost, zvracen\u00ed, dyspepsie, bolesti b\u0159icha<\/li>\n<li>Ospalost, \u00fanava<\/li>\n<li>T\u0159es (jemn\u00fd, postur\u00e1ln\u00ed \u2014 \u010dasto z\u00e1visl\u00fd na d\u00e1vce)<\/li>\n<li>P\u0159\u00edr\u016fstek hmotnosti (10\u201320 % pacient\u016f p\u0159ibere &gt;5 kg)<\/li>\n<li>\u0158\u00eddnut\u00ed nebo vypad\u00e1v\u00e1n\u00ed vlas\u016f (po vysazen\u00ed reverzibiln\u00ed)<\/li>\n<li>Pr\u016fjem nebo z\u00e1cpa<\/li>\n<li>Zv\u00fd\u0161en\u00e1 chu\u0165 k j\u00eddlu<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9, ale d\u016fle\u017eit\u00e9:<\/strong><\/p>\n<ul>\n<li>Trombocytopenie (n\u00edzk\u00fd po\u010det trombocyt\u016f) \u2014 obvykle m\u00edrn\u00e1 a z\u00e1visl\u00e1 na d\u00e1vce; kontrolujte krevn\u00ed obraz p\u0159i ka\u017ed\u00e9 n\u00e1v\u0161t\u011bv\u011b<\/li>\n<li>Hyperamonemick\u00e1 encefalopatie \u2014 ospalost, zmatenost, zvracen\u00ed; m\u016f\u017ee se vyskytnout i p\u0159i norm\u00e1ln\u00edch jatern\u00edch testech; p\u0159i podez\u0159en\u00ed zkontrolujte hladinu amoniaku<\/li>\n<li>P\u0159\u00edznaky syndromu polycystick\u00fdch ovari\u00ed u \u017een \u2014 hyperandrogenismus, menstrua\u010dn\u00ed nepravidelnosti, p\u0159\u00edr\u016fstek hmotnosti<\/li>\n<li>Zv\u00fd\u0161en\u00e9 jatern\u00ed enzymy (\u010dasto asymptomatick\u00e9)<\/li>\n<li>Pankreatitida (vz\u00e1cn\u011b, ale \u017eivot ohro\u017euj\u00edc\u00ed)<\/li>\n<li>Zpomalen\u00e9 kognitivn\u00ed funkce, pot\u00ed\u017ee s pam\u011bt\u00ed<\/li>\n<\/ul>\n<p><strong>Vz\u00e1cn\u00e9, ale vy\u017eaduje okam\u017eitou l\u00e9ka\u0159skou pomoc:<\/strong><\/p>\n<ul>\n<li><strong>Akutn\u00ed fulminantn\u00ed jatern\u00ed selh\u00e1n\u00ed<\/strong> \u2014 zejm\u00e9na u d\u011bt\u00ed mlad\u0161\u00edch 2 let na polyfarmakoterapii. Okam\u017eit\u011b p\u0159eru\u0161te l\u00e9\u010dbu, pokud se objev\u00ed \u017eloutenka, siln\u00e9 zvracen\u00ed nebo nov\u011b vznikl\u00e1 letargie.<\/li>\n<li><strong>Akutn\u00ed pankreatitida<\/strong> \u2014 siln\u00e1 bolest b\u0159icha, zvracen\u00ed<\/li>\n<li><strong>Hyperamonemick\u00e1 encefalopatie<\/strong> s norm\u00e1ln\u00edmi jatern\u00edmi testy \u2014 nov\u011b vznikl\u00e1 zmatenost, ospalost, zvracen\u00ed<\/li>\n<li>Z\u00e1va\u017en\u00e9 ko\u017en\u00ed reakce (Stevens-Johnson\u016fv syndrom, DRESS)<\/li>\n<li>Potla\u010den\u00ed kostn\u00ed d\u0159en\u011b<\/li>\n<li>Z\u00e1va\u017en\u00e9 krv\u00e1cen\u00ed z trombocytopenie nebo dysfunkce krevn\u00edch desti\u010dek<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Varov\u00e1n\u00ed a preventivn\u00ed opat\u0159en\u00ed \u2014 KRITICK\u00c9<\/h2>\n<ul>\n<li><strong>T\u011bhotenstv\u00ed: ABSOLUTN\u00cd KONTRAINDIKACE u migr\u00e9ny (FDA kategorie X) a SILN\u00c9 VAROV\u00c1N\u00cd u epilepsie (kategorie D).<\/strong> Valpro\u00e1t sodn\u00fd je jedn\u00edm z nej\u00fa\u010dinn\u011bj\u0161\u00edch lidsk\u00fdch teratogen\u016f v rutinn\u00ed klinick\u00e9 praxi. Riziko z\u00e1va\u017en\u00fdch vrozen\u00fdch vad (defekty neur\u00e1ln\u00ed trubice, kraniofaci\u00e1ln\u00ed defekty, srde\u010dn\u00ed vady, vady kon\u010detin, hypospadie) je p\u0159ibli\u017en\u011b <strong>10%<\/strong>, plus 30\u201340% riziko v\u00fdznamn\u00e9ho neurov\u00fdvojov\u00e9ho posti\u017een\u00ed (ni\u017e\u0161\u00ed IQ, porucha autistick\u00e9ho spektra) u d\u011bt\u00ed exponovan\u00fdch in utero. Pou\u017e\u00edvejte pouze, pokud nen\u00ed dostupn\u00e1 jin\u00e1 \u00fa\u010dinn\u00e1 alternativa. \u017deny v reproduk\u010dn\u00edm v\u011bku pot\u0159ebuj\u00ed: (1) explicitn\u00ed poradenstv\u00ed o prevenci t\u011bhotenstv\u00ed, (2) spolehlivou antikoncepci po celou dobu l\u00e9\u010dby, (3) suplementaci fol\u00e1tem 5 mg\/den p\u0159i pl\u00e1nov\u00e1n\u00ed t\u011bhotenstv\u00ed, (4) urgentn\u00ed konzultaci specialisty v p\u0159\u00edpad\u011b ot\u011bhotn\u011bn\u00ed.<\/li>\n<li><strong>Hepatotoxicita:<\/strong> nejvy\u0161\u0161\u00ed riziko u d\u011bt\u00ed mlad\u0161\u00edch 2 let na kombinovan\u00e9 antiepileptick\u00e9 l\u00e9\u010db\u011b (vz\u00e1cn\u00e9 u dosp\u011bl\u00fdch na monoterapii). Okam\u017eit\u011b p\u0159eru\u0161te l\u00e9\u010dbu p\u0159i \u017eloutence, siln\u00e9m zvracen\u00ed, letargii nebo zhor\u0161en\u00ed z\u00e1chvat\u016f.<\/li>\n<li><strong>Pankreatitida:<\/strong> vz\u00e1cn\u00e9, ale \u017eivot ohro\u017euj\u00edc\u00ed; idiosynkratick\u00e9, m\u016f\u017ee se objevit kdykoli b\u011bhem l\u00e9\u010dby. P\u0159i siln\u00e9 bolesti b\u0159icha vyhledejte neodkladnou l\u00e9ka\u0159skou pomoc.<\/li>\n<li><strong>Hyperamonemick\u00e1 encefalopatie:<\/strong> m\u016f\u017ee se vyskytnout i p\u0159i norm\u00e1ln\u00edch hodnot\u00e1ch jatern\u00edch test\u016f \u2014 zkontrolujte hladinu amoniaku, pokud se u pacienta u\u017e\u00edvaj\u00edc\u00edho valpro\u00e1t objev\u00ed ospalost, zmatenost nebo zvracen\u00ed.<\/li>\n<li><strong>Mitochondri\u00e1ln\u00ed onemocn\u011bn\u00ed (mutace POLG):<\/strong> absolutn\u00ed kontraindikace \u2014 valpro\u00e1t u t\u00e9to vz\u00e1cn\u00e9 populace zp\u016fsobuje akutn\u00ed selh\u00e1n\u00ed jater. P\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby je vhodn\u00e9 genetick\u00e9 testov\u00e1n\u00ed, pokud existuje rodinn\u00e1 anamn\u00e9za mitochondri\u00e1ln\u00edho onemocn\u011bn\u00ed nebo nevysv\u011btliteln\u00e9ho jatern\u00edho onemocn\u011bn\u00ed.<\/li>\n<li><strong>Poruchy mo\u010dovinov\u00e9ho cyklu:<\/strong> kontraindikace \u2014 valpro\u00e1t vyvol\u00e1v\u00e1 hyperamonemickou encefalopatii.<\/li>\n<li><strong>Riziko krv\u00e1cen\u00ed:<\/strong> valpro\u00e1t naru\u0161uje funkci krevn\u00edch desti\u010dek a m\u016f\u017ee zp\u016fsobit trombocytopenii. Informujte chirurga a pokud mo\u017eno p\u0159eru\u0161te l\u00e9\u010dbu 1\u20132 t\u00fddny p\u0159ed pl\u00e1novan\u00fdm chirurgick\u00fdm z\u00e1krokem.<\/li>\n<li><strong>Pacienti s demenc\u00ed:<\/strong> mimot\u0159\u00eddn\u00ed pou\u017eit\u00ed pro behavior\u00e1ln\u00ed agitaci ji\u017e nen\u00ed doporu\u010dov\u00e1no \u2014 observa\u010dn\u00ed data ukazuj\u00ed zv\u00fd\u0161enou mortalitu.<\/li>\n<li><strong>Nikdy nevysazujte n\u00e1hle<\/strong> u epilepsie \u2014 m\u016f\u017ee vyvolat status epilepticus.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace \u2014 Kdo by NEM\u011aL u\u017e\u00edvat Valprol-CR<\/h2>\n<ul>\n<li>T\u011bhotenstv\u00ed nebo pl\u00e1nov\u00e1n\u00ed t\u011bhotenstv\u00ed (zejm\u00e9na u profylaxe migr\u00e9ny \u2014 absolutn\u00ed kontraindikace)<\/li>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na valpro\u00e1t nebo jakoukoli pomocnou l\u00e1tku tablety<\/li>\n<li>T\u011b\u017ek\u00e9 jatern\u00ed po\u0161kozen\u00ed nebo aktivn\u00ed jatern\u00ed onemocn\u011bn\u00ed<\/li>\n<li>Osobn\u00ed nebo rodinn\u00e1 anamn\u00e9za t\u011b\u017ek\u00e9 jatern\u00ed dysfunkce zp\u016fsoben\u00e9 l\u00e9ky<\/li>\n<li>Mitochondri\u00e1ln\u00ed onemocn\u011bn\u00ed (zejm\u00e9na mutace POLG)<\/li>\n<li>Poruchy mo\u010dovinov\u00e9ho cyklu<\/li>\n<li>Akutn\u00ed porfyrie<\/li>\n<li>D\u011bti mlad\u0161\u00ed 2 let (zejm\u00e9na p\u0159i polyfarmakoterapii \u2014 vysok\u00e9 riziko hepatotoxicity)<\/li>\n<li>Aktivn\u00ed pankreatitida<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Kombinujte s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u00da\u010dinek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Co d\u011blat<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Lamotrigin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Valpro\u00e1t zdvojn\u00e1sobuje hladiny lamotriginu \u2014 v\u00fdrazn\u011b zv\u00fd\u0161en\u00e9 riziko z\u00e1va\u017en\u00e9 vyr\u00e1\u017eky a Stevens-Johnsonova syndromu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sni\u017ete d\u00e1vku lamotriginu o 50 % p\u0159i kombinaci; velmi pomal\u00e1 titrace. Pod odborn\u00fdm dohledem.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Karbapenemy (meropenem, ertapenem, imipenem)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Karbapenemy v\u00fdrazn\u011b sni\u017euj\u00ed hladinu valpro\u00e1tu \u2014 mohou vyvolat z\u00e1chvaty b\u011bhem n\u011bkolika dn\u00ed<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se kombinaci. Pou\u017eijte alternativn\u00ed antibiotikum, pokud je valpro\u00e1t nezbytn\u00fd.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Fenytoin, karbamazepin, fenobarbital (jin\u00e1 antiepileptika)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Obousm\u011brn\u00e9 interakce vazby na proteiny a metabolismu \u2014 nep\u0159edv\u00eddateln\u00e9 \u00fa\u010dinky na oba l\u00e9ky<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitorujte hladiny obou l\u00e1tek; nutn\u00fd dohled specialisty.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aspirin (vysok\u00e9 d\u00e1vky), NSAID<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyt\u011bs\u0148uj\u00ed valpro\u00e1t z albuminu; zvy\u0161uj\u00ed volnou frakci a toxicitu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se vysok\u00fdm d\u00e1vk\u00e1m aspirinu. Sledujte ne\u017e\u00e1douc\u00ed \u00fa\u010dinky valpro\u00e1tu.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin, antikoagulancia<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zv\u00fd\u0161en\u00fd antikoagula\u010dn\u00ed \u00fa\u010dinek (vyt\u011bsn\u011bn\u00ed) a inhibice desti\u010dek valpro\u00e1tem<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitorujte INR \u010dast\u011bji. Sledujte p\u0159\u00edznaky krv\u00e1cen\u00ed.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Topiramate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zv\u00fd\u0161en\u00e9 riziko hyperamon\u00e9mie a encefalopatie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zkontrolujte hladinu amoniaku, pokud se objev\u00ed p\u0159\u00edznaky.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alkohol<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aditivn\u00ed deprese CNS a hepatotoxicita<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Omezte na ob\u010dasn\u00e9 mal\u00e9 mno\u017estv\u00ed; vyhn\u011bte se n\u00e1razov\u00e9mu pit\u00ed.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombinovan\u00e9 peror\u00e1ln\u00ed antikoncepce<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u017d\u00e1dn\u00e1 v\u00fdznamn\u00e1 interakce (na rozd\u00edl od mnoha jin\u00fdch antiepileptik)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombinovan\u00e9 peror\u00e1ln\u00ed antikoncepce z\u016fst\u00e1vaj\u00ed \u00fa\u010dinn\u00e9. Vzhledem k teratogenit\u011b je nutn\u00e1 spolehliv\u00e1 antikoncepce.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Benzodiazepiny<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aditivn\u00ed deprese CNS<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se rutinn\u00ed kombinaci; pou\u017eijte nejni\u017e\u0161\u00ed mo\u017en\u00e9 d\u00e1vky, pokud je kombinace nutn\u00e1.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Pokyny k uchov\u00e1v\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte p\u0159i pokojov\u00e9 teplot\u011b, <strong>15\u201325\u00b0C<\/strong>. Chra\u0148te p\u0159ed sv\u011btlem a vlhkost\u00ed.<\/li>\n<li>Tablety uchov\u00e1vejte v p\u016fvodn\u00edm blistru a\u017e do pou\u017eit\u00ed.<\/li>\n<li>Neskladujte v koupeln\u011b \u2013 vlhkost zkracuje trvanlivost.<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed \u2014 valpro\u00e1t je vysoce teratogenn\u00ed a n\u00e1hodn\u00e9 po\u017eit\u00ed t\u011bhotnou \u010dlenkou dom\u00e1cnosti p\u0159edstavuje v\u00e1\u017en\u00e9 riziko.<\/li>\n<li>Nepou\u017e\u00edvejte po uplynut\u00ed data expirace.<\/li>\n<li>Nepou\u017eit\u00e9 tablety vra\u0165te do l\u00e9k\u00e1rny k odborn\u00e9 likvidaci.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy na MedsBase<\/h2>\n<p>Dal\u0161\u00ed l\u00e9ky skladovan\u00e9 pro epilepsii, bipol\u00e1rn\u00ed poruchu a profylaxi migr\u00e9ny:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/product-category\/neurological-conditions-and-epilepsy\/\">Prohl\u00e9dn\u011bte si v\u0161echny neurologick\u00e9 l\u00e9ky a l\u00e9ky na epilepsii<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/product-category\/mental-health-and-psychiatric-medications\/\">Prohl\u00e9dn\u011bte si v\u0161echny l\u00e9ky na du\u0161evn\u00ed zdrav\u00ed a psychiatrick\u00e9 l\u00e9ky<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/product-category\/anti-migraine\/\">Prohl\u00e9dn\u011bte si l\u00e9ky proti migr\u00e9n\u011b<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">K jak\u00fdm stav\u016fm se Valprol-CR pou\u017e\u00edv\u00e1?<\/h3>\n<p>Valprol-CR (valpro\u00e1t sodn\u00fd + kyselina valproov\u00e1) je schv\u00e1len pro: <strong>r\u016fzn\u00fdch typ\u016f z\u00e1chvat\u016f u epilepsie<\/strong> (generalizovan\u00e9 tonicko-klonick\u00e9, absence, myoklonick\u00e9, parci\u00e1ln\u00ed), <strong>akutn\u00ed m\u00e1nie u bipol\u00e1rn\u00ed poruchy I. typu<\/strong>, a <strong>profylaxe migr\u00e9ny<\/strong> u dosp\u011bl\u00fdch. Je to jeden z nej\u0161irkospektr\u00e1ln\u00edch antiepileptik dostupn\u00fdch na trhu. Mimo schv\u00e1len\u00e9 indikace se n\u011bkdy pou\u017e\u00edv\u00e1 u neuropatick\u00e9 bolesti a behavior\u00e1ln\u00ed agitace u n\u011bkter\u00fdch psychiatrick\u00fdch stav\u016f, ale ji\u017e se nedoporu\u010duje pro behavior\u00e1ln\u00ed agitaci u demence (sign\u00e1l zv\u00fd\u0161en\u00e9 mortality v observa\u010dn\u00edch datech).<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d je Valprol-CR tak nebezpe\u010dn\u00fd v t\u011bhotenstv\u00ed?<\/h3>\n<p>Valpro\u00e1t sodn\u00fd je jedn\u00edm z nejteratogenn\u011bj\u0161\u00edch l\u00e9k\u016f v rutinn\u00ed klinick\u00e9 praxi. Expozice in utero nese p\u0159ibli\u017en\u011b <strong>10% riziko z\u00e1va\u017en\u00fdch vrozen\u00fdch vad<\/strong> (defekty neur\u00e1ln\u00ed trubice, srde\u010dn\u00ed vady, kraniofaci\u00e1ln\u00ed defekty, hypospadie, vady kon\u010detin) plus <strong>30\u201340% riziko v\u00fdznamn\u00e9ho neurov\u00fdvojov\u00e9ho posti\u017een\u00ed<\/strong> (ni\u017e\u0161\u00ed IQ, porucha autistick\u00e9ho spektra). Pro profylaxi migr\u00e9ny FDA klasifikuje tento l\u00e9k jako <strong>T\u011bhotensk\u00e1 kategorie X (absolutn\u00ed kontraindikace)<\/strong>; pro epilepsii kategorie D (pou\u017e\u00edt pouze pokud p\u0159\u00ednos p\u0159ev\u00e1\u017e\u00ed v\u00fdrazn\u00e9 riziko pro plod a nen\u00ed dostupn\u00e1 jin\u00e1 mo\u017enost). \u017deny v reproduk\u010dn\u00edm v\u011bku pot\u0159ebuj\u00ed explicitn\u00ed poradenstv\u00ed, spolehlivou antikoncepci a 5 mg\/den fol\u00e1tu p\u0159ed jak\u00fdmkoli pl\u00e1novan\u00fdm t\u011bhotenstv\u00edm.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d nikdy nesm\u00edm n\u00e1hle vysadit Valprol-CR?<\/h3>\n<p>U epilepsie m\u016f\u017ee n\u00e1hl\u00e9 vysazen\u00ed vyvolat <strong>status epilepticus<\/strong> \u2014 jedn\u00e1 se o l\u00e9ka\u0159skou pohotovost, kdy z\u00e1chvaty samy od sebe nep\u0159estanou, s v\u00fdznamnou \u00famrtnost\u00ed, pokud se nel\u00e9\u010d\u00ed. To se m\u016f\u017ee st\u00e1t i u pacient\u016f, kte\u0159\u00ed byli roky bez z\u00e1chvat\u016f. V\u017edy sni\u017eujte d\u00e1vku postupn\u011b po dobu 2\u20136 t\u00fddn\u016f pod l\u00e9ka\u0159sk\u00fdm dohledem p\u0159i ukon\u010dov\u00e1n\u00ed l\u00e9\u010dby. Stejn\u00e1 opatrnost plat\u00ed pro udr\u017eovac\u00ed terapii bipol\u00e1rn\u00ed poruchy \u2014 n\u00e1hl\u00e9 vysazen\u00ed m\u016f\u017ee vyvolat manickou recidivu.<\/p>\n<h3 class=\"wp-block-heading\">Jak\u00e9 krevn\u00ed testy pot\u0159ebuji p\u0159i u\u017e\u00edv\u00e1n\u00ed Valprol-CR?<\/h3>\n<p><strong>P\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby:<\/strong> testy jatern\u00edch funkc\u00ed (AST, ALT, GGT), kompletn\u00ed krevn\u00ed obraz v\u010detn\u011b po\u010dtu krevn\u00edch desti\u010dek, v\u00fdchoz\u00ed hmotnost, hladina gluk\u00f3zy nala\u010dno. <strong>B\u011bhem l\u00e9\u010dby:<\/strong> opakujte testy jatern\u00edch funkc\u00ed a kompletn\u00ed krevn\u00ed obraz po 1 m\u011bs\u00edci, 3 m\u011bs\u00edc\u00edch, 6 m\u011bs\u00edc\u00edch, pot\u00e9 ro\u010dn\u011b. <strong>P\u0159i nevolnosti:<\/strong> zkontrolujte hladinu amoniaku p\u0159i jak\u00e9koli nov\u00e9 ospalosti, zmatenosti nebo zvracen\u00ed (hyperamonemick\u00e1 encefalopatie se m\u016f\u017ee objevit i p\u0159i norm\u00e1ln\u00edch testech jatern\u00edch funkc\u00ed). U epilepsie pravideln\u011b m\u011b\u0159te hladinu valpro\u00e1tu v s\u00e9ru (c\u00edlov\u00e9 rozmez\u00ed 50\u2013100 \u00b5g\/ml).<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d nesm\u00edm drtit nebo rozd\u011blovat tablety Valprol-CR?<\/h3>\n<p>CR (kontrolovan\u00e9 uvol\u0148ov\u00e1n\u00ed) povlak je to, co zaji\u0161\u0165uje prodlou\u017een\u00e9 uvol\u0148ov\u00e1n\u00ed l\u00e9ku po dobu 12\u201324 hodin. Rozdrcen\u00ed nebo rozd\u011blen\u00ed tablety zni\u010d\u00ed povlak a zp\u016fsob\u00ed \u201cvysyp\u00e1n\u00ed d\u00e1vky\u201d \u2014 cel\u00e1 d\u00e1vka se vst\u0159eb\u00e1 b\u011bhem 2\u20133 hodin, co\u017e vede k velmi vysok\u00fdm vrcholov\u00fdm hladin\u00e1m s t\u011b\u017ekou ospalost\u00ed, t\u0159esem, gastrointestin\u00e1ln\u00edmi pot\u00ed\u017eemi a n\u011bkdy hyperamonemickou encefalopati\u00ed. Pokud je pot\u0159eba men\u0161\u00ed d\u00e1vka, pou\u017eijte valpro\u00e1t s okam\u017eit\u00fdm uvol\u0148ov\u00e1n\u00edm nebo p\u0159ejd\u011bte na ni\u017e\u0161\u00ed d\u00e1vku 200 mg CR m\u00edsto rozd\u011blen\u00ed tablety 750 mg CR.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsob\u00ed Valprol-CR p\u0159ib\u00fdv\u00e1n\u00ed na v\u00e1ze nebo vypad\u00e1v\u00e1n\u00ed vlas\u016f?<\/h3>\n<p>Oba ne\u017e\u00e1douc\u00ed \u00fa\u010dinky jsou \u010dast\u00e9. <strong>P\u0159ib\u00fdv\u00e1n\u00ed na v\u00e1ze<\/strong> postihuje 10\u201320 % pacient\u016f (obvykle 5\u201310 kg b\u011bhem prvn\u00edch 6\u201312 m\u011bs\u00edc\u016f) a je zp\u016fsobeno zv\u00fd\u0161enou chut\u00ed k j\u00eddlu a metabolick\u00fdmi \u00fa\u010dinky. Zm\u00edrn\u011bte to konzistentn\u00ed stravou a cvi\u010den\u00edm. <strong>\u0158\u00eddnut\u00ed nebo vypad\u00e1v\u00e1n\u00ed vlas\u016f<\/strong> postihuje a\u017e 10 % pacient\u016f, obvykle za\u010d\u00edn\u00e1 v prvn\u00edch 3\u20136 m\u011bs\u00edc\u00edch a je reverzibiln\u00ed p\u0159i sn\u00ed\u017een\u00ed d\u00e1vky nebo vysazen\u00ed. Suplementace zinku a selenu se n\u011bkdy pou\u017e\u00edv\u00e1 (omezen\u00e9 d\u016fkazy).<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee se Valprol-CR pou\u017e\u00edvat s lamotriginem?<\/h3>\n<p>Ano, ale s extr\u00e9mn\u00ed opatrnost\u00ed. Valpro\u00e1t <strong>zdvojn\u00e1sobuje hladiny lamotriginu<\/strong> inhibic\u00ed jeho metabolismu prudce zvy\u0161uje riziko z\u00e1va\u017en\u00e9 vyr\u00e1\u017eky a Stevens-Johnsonova syndromu \u2014 nejz\u00e1va\u017en\u011bj\u0161\u00edho vedlej\u0161\u00edho \u00fa\u010dinku lamotriginu. Tato kombinace se n\u011bkdy pou\u017e\u00edv\u00e1 (m\u00e1 dobr\u00e9 kognitivn\u00ed a protiz\u00e1chvatov\u00e9 vlastnosti), ale lamotrigin mus\u00ed b\u00fdt zah\u00e1jen <strong>polovi\u010dn\u00ed obvykl\u00e9 d\u00e1vce<\/strong> s mnohem pomalej\u0161\u00edm zvy\u0161ov\u00e1n\u00edm d\u00e1vky (12t\u00fddenn\u00ed protokol). Nezbytn\u00fd je odborn\u00fd dohled.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d n\u011bkter\u00e1 antibiotika (karbapenemy) tak nebezpe\u010dn\u011b interaguj\u00ed s Valprol-CR?<\/h3>\n<p>Karbapenemov\u00e1 antibiotika (meropenem, ertapenem, imipenem) <strong>v\u00fdrazn\u011b sni\u017euj\u00ed hladinu valpro\u00e1tu<\/strong> \u2014 n\u011bkdy o v\u00edce ne\u017e 90 % b\u011bhem 1\u20133 dn\u016f \u2014 prost\u0159ednictv\u00edm \u0161patn\u011b pochopen\u00e9ho mechanismu, kter\u00fd m\u016f\u017ee zahrnovat enterohepat\u00e1ln\u00ed recirkulaci. V\u00fdsledkem je n\u00e1hl\u00e1 ztr\u00e1ta kontroly z\u00e1chvat\u016f i u pacient\u016f se stabiln\u00edmi terapeutick\u00fdmi hladinami po cel\u00e9 roky. <strong>T\u00e9to kombinaci se vyhn\u011bte.<\/strong> Pokud pacient u\u017e\u00edvaj\u00edc\u00ed valpro\u00e1t pot\u0159ebuje karbapenem (nap\u0159. p\u0159i nozokomi\u00e1ln\u00ed infekci), p\u0159eve\u010fte antibiotikum na alternativu NEBO p\u0159ed zah\u00e1jen\u00edm pod\u00e1v\u00e1n\u00ed karbapenemu zm\u011b\u0148te antiepileptikum.<\/p>\n<h3 class=\"wp-block-heading\">Je Valprol-CR vhodn\u00fd pro behavior\u00e1ln\u00ed agitaci u demence?<\/h3>\n<p><strong>Ji\u017e se nedoporu\u010duje.<\/strong> Mimol\u00e9kov\u00e9 pou\u017eit\u00ed valpro\u00e1tu pro behavior\u00e1ln\u00ed agitaci u Alzheimerovy choroby a jin\u00fdch demenc\u00ed bylo b\u011b\u017en\u00e9, dokud observa\u010dn\u00ed studie neprok\u00e1zaly <strong>sign\u00e1l zv\u00fd\u0161en\u00e9 mortality<\/strong>, podobn\u00fd sign\u00e1lu, kter\u00fd vedl k varov\u00e1n\u00ed v \u010dern\u00e9m r\u00e1me\u010dku u antipsychotik u demence. Sou\u010dasn\u00e9 sm\u011brnice up\u0159ednost\u0148uj\u00ed nejprve nefarmakologick\u00e9 p\u0159\u00edstupy, pot\u00e9 kr\u00e1tkodob\u00e9 pod\u00e1v\u00e1n\u00ed n\u00edzk\u00fdch d\u00e1vek risperidonu nebo kvetiapinu v p\u0159\u00edpad\u011b pot\u0159eby, p\u0159i\u010dem\u017e valpro\u00e1t je vyhrazen pro velmi specifick\u00e9 p\u0159\u00edpady pod odborn\u00fdm dohledem.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/gabatop\/\">Gabatop<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/gabimax\/\">Gabimax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/xepar\/\">Xepar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tenof-em\/\">Tenof EM<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/cresar\/\">Cresar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Valprol-CR (sodn\u00e1 s\u016fl valpro\u00e1tu CR 200\u2013500 mg) \u2014 antikonvulzivum a stabiliz\u00e1tor n\u00e1lady pro epilepsii, bipol\u00e1rn\u00ed m\u00e1nii a profylaxi migr\u00e9ny. Vyrovnan\u011bj\u0161\u00ed hladina \u2014 dvakr\u00e1t denn\u011b pod\u00e1van\u00e9 tablety s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm.<\/p>","protected":false},"featured_media":60657,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3906,3468],"product_tag":[4677,4898,4899],"class_list":{"0":"post-60656","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_cat-neurological-conditions-and-epilepsy","10":"product_tag-sodium-valproate","11":"product_tag-valproic-acid","12":"product_tag-valprol-cr","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/60656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=60656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/60657"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=60656"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=60656"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=60656"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=60656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}